Key opinion leaders from academia with expertise in genetic frontotemporal dementia (FTD), multiple sclerosis, biomarkers and drug development, and the use of neurofilament light (NfL) as a biomarker in neurodegenerative diseases were invited speakers. Here, NEFL is linked to frontotemporal dementia.